DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,092 | -9.2% | 11,957 | +0.5% | 0.00% | – |
| Q2 2023 | $167,468 | -4.5% | 11,894 | +4.8% | 0.00% | -100.0% |
| Q1 2023 | $175,296 | -7.0% | 11,346 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $188,567 | -3.8% | 11,505 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $196,000 | +45.2% | 10,587 | +3.6% | 0.00% | – |
| Q2 2022 | $135,000 | +8.0% | 10,219 | -24.4% | 0.00% | – |
| Q1 2022 | $125,000 | -23.8% | 13,515 | -19.7% | 0.00% | – |
| Q4 2021 | $164,000 | -72.3% | 16,833 | -3.5% | 0.00% | -100.0% |
| Q3 2021 | $593,000 | -21.5% | 17,442 | -15.4% | 0.00% | 0.0% |
| Q2 2021 | $755,000 | -7.9% | 20,626 | +12.8% | 0.00% | -33.3% |
| Q1 2021 | $820,000 | -16.7% | 18,285 | +6.1% | 0.00% | -25.0% |
| Q4 2020 | $984,000 | +40.4% | 17,235 | +26.1% | 0.00% | +33.3% |
| Q3 2020 | $701,000 | -16.2% | 13,672 | -2.4% | 0.00% | -25.0% |
| Q2 2020 | $837,000 | +146.2% | 14,009 | +69.7% | 0.00% | +100.0% |
| Q1 2020 | $340,000 | -60.1% | 8,254 | -39.8% | 0.00% | -50.0% |
| Q4 2019 | $853,000 | +62.8% | 13,703 | -11.2% | 0.00% | +33.3% |
| Q3 2019 | $524,000 | +92.6% | 15,432 | +27.8% | 0.00% | +50.0% |
| Q2 2019 | $272,000 | -14.7% | 12,076 | -12.2% | 0.00% | 0.0% |
| Q1 2019 | $319,000 | +11.1% | 13,750 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $287,000 | – | 13,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |